Role of the MexAB-OprM efflux pump of Pseudomonas aeruginosa in tolerance to tea tree (Melaleuca alternifolia) oil and its monoterpene components terpinen-4-ol, 1,8-cineole, and α-terpineol ∇

Applied and Environmental Microbiology

Volumn 74, Issue 6, 2008, Pages 1932-1935

  Papadopoulos, Chelsea J ^a   Carson, Christine F ^a   Chang, Barbara J ^a   Riley, Thomas V ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MONOTERPENE COMPONENTS; PSEUDOMONAS AERUGINOSA;

ALCOHOLS; BACTERIA; MUTAGENESIS; VEGETABLE OILS;

PLANTS (BOTANY);

CARRIER PROTEIN; CINEOLE; PROTEIN MEXAB OPRM; TEA TREE OIL; TERPENE DERIVATIVE; TERPINEN 4 OL; TERPINEOL; UNCLASSIFIED DRUG;

ALCOHOL; BACTERIUM; IDENTIFICATION METHOD; MONOTERPENE; MUTATION; OIL; TEA; TOLERANCE;

ARTICLE; NONHUMAN; PSEUDOMONAS AERUGINOSA;

BACTERIAL OUTER MEMBRANE PROTEINS; CYCLOHEXANOLS; CYCLOHEXENES; MELALEUCA; MEMBRANE TRANSPORT PROTEINS; MONOTERPENES; MUTATION; PSEUDOMONAS AERUGINOSA; TEA TREE OIL;

MELALEUCA ALTERNIFOLIA; PSEUDOMONAS AERUGINOSA;

EID: 40849142161     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.02334-07     Document Type: Article

References (32)

1. Banes-Marshall, L., P. Cawley, and C. A. Phillips. 2001. In vitro activity of Melaleuca alternifolia (tea tree) oil against bacterial and Candida spp. isolates from clinical specimens. Br. J. Biomed. Sci. 58:139-145.
2. Carson, C. F., K. A. Hammer, and T. V. Riley. 2006. Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clin. Microbiol. Rev. 19:50-62.
3. Carson, C. F., B. J. Mee, and T. V. Riley. 2002. Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrob. Agents Chemother. 46:1914-1920.
4. Choi, K. H., A. Kumar, and H. P. Schweizer. 2005. A 10 min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells: application for DNA fragment transfer between chromosomes and plasmid transformation. J. Microbiol. Methods 64:391-397.
5. Chuanchuen, R., K. Beinlich, T. T. Hoang, A. Becher, R. R. Karkhoff-Schweizer, and H. P. Schweizer. 2001. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob. Agents Chemother. 45:428-432.
6. Chuanchuen, R., R. R. Karkhoff-Schweizer, and H. P. Schweizer. 2003. High-level triclosan resistance in Pseudomonas aeruginosa is solely a result of efflux. Am. J. Infect. Control 31:124-127.
7. CLSI. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A7. CLSI, Wayne, PA.
8. Coban, A. Y., B. Ekinci, and B. Durupinar. 2004. A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates. Chemotherapy 50:22-26.
9. Cox, S. D., and J. L. Markham. 2007. Susceptibility and intrinsic tolerance of Pseudomonas aeruginosa to selected plant volatile compounds. J. Appl. Microbiol. 103:930-936.
10. De Kievit, T. R., M. D. Parkins, R. J. Gillis, R. Srikumar, H. Ceri, K. Poole, B. H. Iglewski, and D. G. Storey. 2001. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 45:1761-1770.
11. Driscoll, J. A., S. L. Brody, and M. H. Kollef. 2007. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67:351-368.
12. Hancock, R. E. 1998. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin. Infect. Dis. 27:S93-S99.
13. Hancock, R. E., and A. M. Carey. 1979. Outer membrane of Pseudomonas aeruginosa: heat-2-mercaptoethanol-modifiable proteins. J. Bacteriol. 140:902-910.
14. Hirakata, Y., R. Srikumar, K. Poole, N. Gotoh, T. Suematsu, S. Kohno, S. Kamihira, R. E. Hancock, and D. P. Speert. 2002. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J. Exp. Med. 196:109-118.
15. International Organisation for Standardisation. 2004. ISO 4730:2004, oil of Melaleuca, terpinen-4-ol type (tea tree oil). International Organisation for Standardisation, Geneva, Switzerland.
16. Jiang, X., Z. Zhang, M. Li, D. Zhou, F. Ruan, and Y. Lu. 2006. Detection of extended-spectrum β-lactamases in clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 50:2990-2995.
17. Keen, N. T., S. Tamaki, D. Kobayashi, and D. Trollinger. 1988. Improved broad-host-range plasmids for DNA cloning in gram-negative bacteria. Gene 70:191-197.
18. Lee, A., W. Mao, M. S. Warren, A. Mistry, K. Hoshino, R. Okumura, H. Ishida, and O. Lomovskaya. 2000. Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance. J. Bacteriol. 182:3142-3150.
19. Li, X. Z., K. Poole, and H. Nikaido. 2003. Contributions of MexAB-OprM and an EmrE homolog to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes. Antimicrob. Agents Chemother. 47:27-33.
20. Li, X. Z., L. Zhang, and K. Poole. 1998. Role of the multidrug efflux systems of Pseudomonas aeruginosa in organic solvent tolerance. J. Bacteriol. 180:2987-2991.
21. Li, X. Z., L. Zhang, R. Srikumar, and K. Poole. 1998. Beta-lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 42:399-403.
22. Longbottom, C. J., C. F. Carson, K. A. Hammer, B. J. Mee, and T. V. Riley. 2004. Tolerance of Pseudomonas aeruginosa to Melaleuca alternifolia (tea tree) oil is associated with the outer membrane and energy-dependent cellular processes. J. Antimicrob. Chemother. 54:386-392.
23. Mann, C. M., S. D. Cox, and J. L. Markham. 2000. The outer membrane of Pseudomonas aeruginosa NCTC 6749 contributes to its tolerance to the essential oil of Melaleuca alternifolia (tea tree oil). Lett. Appl. Microbiol. 30:294-297.
24. Masuda, N., E. Sakagawa, S. Ohya, N. Gotoh, H. Tsujimoto, and T. Nishino. 2000. Contribution of the MexX-MexY-OprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:2242-2246.
25. Messager, S., K. A. Hammer, C. F. Carson, and T. V. Riley. 2005. Assessment of the antibacterial activity of tea tree oil using the European EN 1276 and EN 12054 standard suspension tests. J. Hosp. Infect. 59:113-125.
26. Okii, M., S. Iyobe, and S. Mitsuhashi. 1983. Mapping of the gene specifying aminoglycoside 3′-phosphotransferase II on the Pseudomonas aeruginosa chromosome. J. Bacteriol. 155:643-649.
27. Papadopoulos, C. J., C. F. Carson, K. A. Hammer, and T. V. Riley. 2006. Susceptibility of pseudomonads to Melaleuca alternifolia (tea tree) oil and components. J. Antimicrob. Chemother. 58:449-451.
28. Pearson, J. P., C. Van Delden, and B. H. Iglewski. 1999. Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals. J. Bacteriol. 181:1203-1210.
29. Poole, K. 2001. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J. Mol. Microbiol. Biotechnol. 3:255-264.
30. Schweizer, H. P. 1998. Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems. Antimicrob. Agents Chemother. 42:394-398.
31. Srikumar, R., T. Kon, N. Gotoh, and K. Poole. 1998. Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain. Antimicrob. Agents Chemother. 42:65-71.
32. Srikumar, R., X. Z. Li, and K. Poole. 1997. Inner membrane efflux components are responsible for beta-lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa. J. Bacteriol. 179:7875-7881.